English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52609224    ???header.onlineuser??? :  898
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"yeh d c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 33  (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2023 Neoadjuvant pegylated liposomal doxorubicin- and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case–control study Tsai, J.-H.;Li, C.-L.;Yeh, D.-C.;Hung, C.-S.;Hung, C.-C.;Lin, C.-Y.;Kuo, Y.-L.
臺大學術典藏 2022-08-23T02:35:03Z Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders Dai M.-S.; Liu L.-C.; Wang M.-Y.; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; SUNG-HSIN KUO; Huang C.-S.; Yeh D.-C.; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Lin P.-H.
臺大學術典藏 2022-08-12T06:27:35Z EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid Yeh D.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Wang H.-C.; Rau K.-M.; Feng Y.-H.; Chang Y.-C.; Lee K.-D.; Ou-Yang F.; Kuo W.-H.; KING-JEN CHANG; Lin Y.-C.; Tseng L.-M.; Hou M.-F.
臺大學術典藏 2022-07-29T03:18:01Z Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients Lin P.-H.; Chen S.-C.; Tseng L.-M.; Chang K.-J.; Huang A.-C.; Cheng K.-C.; Yang K.; Wu H.-C.; Chao T.-Y.; Chang Y.-C.; Lin P.-C.; Kuo W.-H.; Kuo W.-L.; Lin C.-H.; Chen H.-M.; Yeh D.-C.; Liu L.-C.; Liu C.-Y.; MING-YANG WANG; Lo C.; Lu Y.-S.; Huang C.-S.
臺大學術典藏 2022-07-29T03:18:01Z Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders Lin P.-H.; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Yeh D.-C.; Dai M.-S.; Liu L.-C.; MING-YANG WANG; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; Kuo S.-H.; Huang C.-S.
臺大學術典藏 2022-05-11T08:25:41Z Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients Lin P.-H.; Chen S.-C.; Tseng L.-M.; Chang K.-J.; Huang A.-C.; Cheng K.-C.; Yang K.; Wu H.-C.; Chao T.-Y.; Chang Y.-C.; Lin P.-C.; Kuo W.-H.; Kuo W.-L.; CHING-HUNG LIN; Chen H.-M.; Yeh D.-C.; Liu L.-C.; Liu C.-Y.; Wang M.-Y.; Lo C.; Lu Y.-S.; Huang C.-S.
臺大學術典藏 2022-03-15T05:39:30Z Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy Lu Y.-S.; WEI-WU CHEN; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; Cheng A.-L.; Taiwan Breast Cancer Consortium
臺大學術典藏 2022-03-15T05:39:29Z A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis Wu P.-F.; Lin C.-H.; Kuo C.-H.; WEI-WU CHEN; Yeh D.-C.; Liao H.-W.; Huang S.-M.; Cheng A.-L.; Lu Y.-S.
臺大學術典藏 2022-03-15T05:39:25Z A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer WEI-WU CHEN; Yeh D.-C.; Chao T.-Y.; Lin C.-H.; Chow L.W.-C.; Chang D.-Y.; Hsieh Y.-Y.; Huang S.-M.; Cheng A.-L.; Lu Y.-S.; Taiwan Breast Cancer Consortium
臺大學術典藏 2022-03-10T02:31:33Z Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients PO-HAN LIN; Chen S.-C.; Tseng L.-M.; Chang K.-J.; Huang A.-C.; Cheng K.-C.; Yang K.; Wu H.-C.; Chao T.-Y.; Chang Y.-C.; Lin P.-C.; Kuo W.-H.; Kuo W.-L.; Lin C.-H.; Chen H.-M.; Yeh D.-C.; Liu L.-C.; Liu C.-Y.; Wang M.-Y.; Lo C.; Lu Y.-S.; Huang C.-S.

Showing items 1-10 of 33  (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page